ꢀꢀꢀꢁ
4ꢀ ꢀM. Abbasi et al.: Highly functionalized tetrahydropiperidines
NH); 13C NMR (100 MHz, CDCl3): δ 14.4, 20.5, 21.2, 21.7, 34.4, 56.2, 58.2,
60.1, 95.1, 113.5, 125.2, 125.5, 127.3, 127.6, 127.8, 128.7, 126.5, 127.2, 128.8,
129.3, 130.1, 135.2, 138.9, 139.4, 146.3, 154.4, 169.6; MS (EI, 70 eV): m/z
Table 4ꢀAntibacterial activity of the synthesized piperidine
derivatives and reference drugs.
+
530 [M ]. Anal. Calcd for C36H38N2O2: C, 81.47; H, 7.22; N, 5.28. Found:
Compound
ꢁ
ꢁ
S. enterica
ꢁ
ꢁ
E. coli
C, 81.40; H, 7.43; N, 5.34.
DDa
ꢁ MICb
DD
ꢁ MIC
Ethyl 2,6-bis(4-chlorophenyl)-1-(3-iodophenyl)-4-((3-iodophenyl)
amino)-1,2,5,6-tetrahydropyridine-3-carboxylate (4s)ꢁWhite solid;
mp 189–190°C; IR (KBr): 3234, 3069, 2956, 2875,1657, 1604, 1459, 1375,
1249, 1075 cm-1; 1H NMR (400 MHz, CDCl3): δ 1.47 (3H, t, J ꢀ=ꢀ 7.5 Hz, CH3),
2.69 (1H, dd, J ꢀ=ꢀ 14.6, 2.7 Hz, C5-H′), 2.82 (1H, dd, J ꢀ=ꢀ 14.6, 5.4 Hz, C5-H″),
4.35 (1H, m, OCH2), 4.47 (1H, m, OCH2), 5.06 (1H, m, C6-H), 6.26 (1H,
s, C2-H), 6.37–6.46 (4H, m, ArH), 6.55 (1H, s, ArH), 6.74 (2H, d, J ꢀ=ꢀ 7.6
Hz, ArH), 6.93–7.24 (9H, m, ArH), 10.29 (1H, s, NH); 13C NMR (100 MHz,
CDCl3): δ 16.4, 33.9, 55.4, 59.1, 61.9, 99.2, 113.4, 117.4, 121.7, 123.8, 124.2,
125.4, 128.4, 128.8, 129.2, 129.6, 129.9, 130.2, 131.4, 131.7, 133.9, 134.7,
4q
4s
4t
ꢂ
ꢂ
ꢂ
ꢂ
11
10
9
12
10
10
ꢂ 750
ꢂ ꢂ>ꢂ1000
ꢂ NA
ꢂ 750
ꢂ 125
ꢂ 150
ꢂ
ꢂ
ꢂ
ꢂ
ꢂ
ꢂ
–
–
ꢂ
ꢂ
ꢂ
–
–
–
–
4w
13
15
12
ꢂ 500
ꢂ 100
ꢂ 125
Streptomycin (standard)ꢂ
Rifampicin (standard)
ꢂ
Compounds with no sensitivity are not reported.
aDiffusion diameter (mm).
bMinimum inhibitory concentration (μg/mL).
+
141.4, 142.5, 142.8, 147.9, 155.8, 168.9; MS (EI, 70 eV): m/z 793 [M ]. Anal.
Calcd for C32H26Cl2I2N2O2: C, 48.33; H, 3.30; N, 3.52. Found: C, 48.39; H,
3.21; N, 3.69.
synthesized products exhibit noticeable antibacterial
activity.
Antimicrobial activity assays
Experimental
Antimicrobial activity was determined against three
Gram-positive bacteria (S. epidermidis ATCC 12228, S.
aureus ATCC 29737, and B. subtilis ATCC 6633) and three
Gram-negative bacteria (S. enteriae PTCC 1188, E. coli
ATCC 10536, and K. pneumonia ATCC 10031), an yeast (C.
albicans ATCC 10231), and a fungus (A. niger ATCC 16404).
Antimicrobial activities of the samples were determined
by disc diffusion method through determination of a
diameter of inhibition zones [28]. Bacterial strains which
were sensitive to the samples in the disc diffusion assay
were chosen to study minimal inhibition concentration
(MIC) using a micro-well dilution assay method [29].
Streptomycin and rifampicin for bacteria and nystatin for
yeast were used as standard reference drugs under con-
centration conditions identical to that of test compounds.
All reagents were purchased from Merck and Aldrich and used with-
out further purification. Melting points were recorded on an Electro-
thermal type 9300 apparatus. FT-IR spectra were recorded using KBr
1
disks on an Avatar 370 FT-IR Thermo Nicolet spectrometer. H NMR
and 13C NMR spectra were collected on a Bruker Avance 400 spec-
trometer. Mass spectra were obtained on a Varian Mat CH-7 spectrom-
eter. Elemental analysis was performed on a Thermo Finnigan Flash
EA microanalyzer.
General procedure for the preparation of piperidines
4a–w
A solution of aniline or substituted aniline (2 mmol), ethyl acetoac-
etate (1 mmol), TiCl2·2H2O (15 mol%) in 96% EtOH (5 mL) was stirred
at room temperature. After 20 min, benzaldehyde or substituted
benzaldehyde (2 mmol) was added and the mixture was stirred for
the time indicated in Table 3. After the completion of the reaction
as monitored by TLC using CHCl3/MeOH (9:1) as eluent, the resulting
solid was filtered off, washed with EtOH (2ꢀ×ꢀ20 mL) and crystallized
from EtOH. The crude product found in the mother liquor was further
purified by column chromatography using CHCl3/MeOH (20:1) as elu-
ent and then crystallized from EtOH. Products prepared previously
are listed in Table 3.
References
[1] Brauch, S.; Van Berkel, S. S.; Westermann, B. Higher-order mul-
ticomponent reactions: beyond four reactants. Chem. Soc. Rev.
2013, 42, 4948–4962.
[2] Gu,Y. Multicomponent reactions in unconventional solvents:
state of the art. Green Chem. 2012, 14, 2091–2128.
[3] Shaabani, S.; Shaabani, A.; Ng, S. W. One-pot synthesis of
coumarin-3-carboxamides containing a triazole ring via an
isocyanide-based six-component reaction. ACS. Comb. Sci.
2014, 16, 176–183.
[4] Marcus, B.; Pankaj, C.; Robert, H.; Gerhard, R.; Dieter, E.
Asymmetric synthesis of tetrahydropyridines via an organocata-
lytic one-pot multicomponent michael/aza-Henry/cyclization
triple domino reaction. Org. Lett. 2014, 16, 6012–6015.
Ethyl 2,6-di-m-tolyl-1-(p-tolyl)-4-(p-tolylamino)-1,2,5,6-tetrahy-
dropyridine-3-carboxylate (4j)ꢁWhite solid; mp 181–182°C; IR
(KBr): 3249, 3068, 2956, 2869, 1649, 1585, 1452, 1372, 1249, 1075 cm-1; 1H
NMR (400 MHz, CDCl3): δ 1.46 (3H, t, J ꢀ=ꢀ 7.2 Hz, CH3), 2.17 (3H, s, CH3,
at phenyl), 2.27 (3H, s, CH3, at phenyl), 2.32 (6H, m, CH3, at phenyl),
2.70 (1H, dd, J ꢀ=ꢀ 15.2, 2.2 Hz, C5-H′), 2.83 (1H, dd, J ꢀ=ꢀ 15.2, 5.4 Hz, C5-
H″), 4.33 (1H, m, OCH2), 4.47 (1H, m, OCH2), 5.08 (1H, m, C6-H), 6.15
(2H, m, ArH), 6.37 (1H, s, C2-H), 6.45 (2H, m, ArH), 6.89 (3H, d, J ꢀ=ꢀ
10.5 Hz), 6.95 (2H, d, J ꢀ=ꢀ 7.6 Hz), 7.03–7.26 (7H, m, ArH), 10.19 (1H, s,
Unauthenticated
Download Date | 5/12/16 10:19 PM